Form 4: Hims & Hers CFO Oluyemi Okupe Reports Stock Transactions

Hims & Hers Health, Inc. CFO Oluyemi Okupe reports the acquisition and disposal of company stock and restricted stock units on December 13, 2024.

Summary

• Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., reported transactions involving the company's Class A Common Stock and Restricted Stock Units (RSUs).
• On December 13, 2024, Mr. Okupe acquired 93,718 shares of Class A Common Stock through the vesting of RSUs.
• On the same day, 51,573 shares of Class A Common Stock were disposed of at a price of $30.02 per share to cover tax obligations related to the vesting of RSUs.
• Mr. Okupe also had 52,396, 18,334 and 22,988 RSUs vest on December 13, 2024.
• Following these transactions, Mr. Okupe directly owns 151,537 shares of Class A Common Stock and 725,831 RSUs.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative in itself.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies.

Comparison to Industry Standards

• Stock transactions and RSU vesting are standard forms of compensation for executives in publicly traded companies.
• The tax withholding process is a common practice to cover tax liabilities associated with equity compensation.
• The vesting schedules described are typical for RSU grants.

Stakeholder Impact

• The transactions have a minor impact on the total number of shares outstanding.
• The transactions are part of the executive compensation plan and are not expected to have a significant impact on the company's operations.

Key Dates

Keywords

Hims & Hers Health, Oluyemi Okupe, CFO, stock transaction, restricted stock units, RSU, Class A Common Stock, insider trading, SEC Form 4